{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:06:29Z","timestamp":1792069589418,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Arabian Gulf University R&EC"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.cyto.2014.11.030","type":"journal-article","created":{"date-parts":[[2015,1,5]],"date-time":"2015-01-05T18:30:57Z","timestamp":1420482657000},"page":"43-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Serum IL-6, IL-10, and TNF\u03b1 levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition"],"prefix":"10.1016","volume":"72","author":[{"given":"Sameh","family":"Sarray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layal R.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lisa Saldanha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebah H.","family":"Al-Habboubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najat","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim Y.","family":"Almawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2014.11.030_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03630260802625709","article-title":"Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion","volume":"33","author":"Conran","year":"2009","journal-title":"Hemoglobin"},{"key":"10.1016\/j.cyto.2014.11.030_b0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/0929867013373778","article-title":"Sickle cell anemia and antisickling agents then and now","volume":"8","author":"Mehanna","year":"2001","journal-title":"Curr Med Chem"},{"issue":"12","key":"10.1016\/j.cyto.2014.11.030_b0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-bioeng-070909-105339","article-title":"Sickle cell biomechanics","volume":"15","author":"Barabino","year":"2010","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.cyto.2014.11.030_b0020","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.hoc.2005.08.002","article-title":"Sickle cell vaso-occlusion","volume":"195","author":"Chiang","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.cyto.2014.11.030_b0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00062752-200203000-00003","article-title":"Sickle cell vaso-occlusion: multistep and multicellular paradigm","volume":"92","author":"Frenette","year":"2002","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.cyto.2014.11.030_b0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199107043250103","article-title":"Pain in sickle cell disease: rates and risk factors","volume":"325","author":"Platt","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2014.11.030_b0035","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2014.11.030_b0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bcmd.2010.08.003","article-title":"The relation of C-reactive protein to vasoocclusive crisis in children with sickle cell disease","volume":"45","author":"Mohammed","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.cyto.2014.11.030_b0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0609.1998.tb01060.x","article-title":"Acute phase proteins and interleukins in steady state sickle cell disease","volume":"61","author":"Bourantas","year":"1998","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cyto.2014.11.030_b0050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/jcp.47.2.166","article-title":"Monitoring the acute phase response to vaso-occlusive crisis in sickle cell disease","volume":"47","author":"Stuart","year":"1994","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cyto.2014.11.030_b0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1189\/jlb.0708445","article-title":"Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy","volume":"85","author":"Lanaro","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cyto.2014.11.030_b0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s002770000173","article-title":"The role of cytokines in sickle cell disease","volume":"79","author":"Makis","year":"2000","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cyto.2014.11.030_b0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cyto.2013.10.009","article-title":"Chronic inflammatory state in sickle cell anemia patients is associated with HBB(\u2217)S haplotype","volume":"65","author":"Bandeira","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2014.11.030_b0070","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000204452","article-title":"Level of tumor necrosis factor alpha\/cachectin (TNF alpha) in sera from patients with sickle cell disease","volume":"90","author":"Malave","year":"1993","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cyto.2014.11.030_b0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1684\/ecn.2013.0328","article-title":"Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition","volume":"24","author":"Keikhaei","year":"2013","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.cyto.2014.11.030_b0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","article-title":"Biology of interleukin-10","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cyto.2014.11.030_b0085","doi-asserted-by":"crossref","first-page":"e79445","DOI":"10.1371\/journal.pone.0079445","article-title":"IL-10 inhibits the NF-\u03baB and ERK\/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in Trypanosoma cruzi-infected cardiomyocytes","volume":"8","author":"Hovsepian","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2014.11.030_b0090","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/978-3-211-45295-0_56","article-title":"Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of interleukin 10","volume":"70","author":"Qian","year":"2006","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.cyto.2014.11.030_b0095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/SHK.0b013e318278ae36","article-title":"Interleukin 10 antioxidant effect decreases leukocytes\/endothelial interaction induced by tumor necrosis factor \u03b1","volume":"39","author":"Huet","year":"2013","journal-title":"Shock"},{"key":"10.1016\/j.cyto.2014.11.030_b0100","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/ajh.23488","article-title":"Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease","volume":"88","author":"Bao","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cyto.2014.11.030_b0105","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2141.2006.06277.x","article-title":"Oxidative stress and inflammation in iron-overloaded patients with beta thalassaemia or sickle cell disease","volume":"135","author":"Walter","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cyto.2014.11.030_b0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5581\/1516-8484.20130011","article-title":"Impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemia","volume":"35","author":"Barbosa","year":"2013","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.cyto.2014.11.030_b0115","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/CVI.00145-09","article-title":"Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis","volume":"17","author":"Musa","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cyto.2014.11.030_b0120","doi-asserted-by":"crossref","first-page":"e68929","DOI":"10.1371\/journal.pone.0068929","article-title":"Blood viscosity and the expression of inflammatory and adhesion markers in homozygous sickle cell disease subjects with chronic leg ulcers","volume":"8","author":"Bowers","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2014.11.030_b0125","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1182\/blood.V92.7.2551","article-title":"Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis","volume":"92","author":"Graido-Gonzalez","year":"1998","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cyto.2014.11.030_b0130","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ajh.23736","article-title":"Reduction in serum IL-10 levels is a surrogate marker for predicting vaso-occlusive crisis in sickle cell disease","volume":"89","author":"Sarray","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cyto.2014.11.030_b0135","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.4049\/jimmunol.0902594","article-title":"Hypoxia-mediated expression of 5-lipoxygenase-activating protein involves HIF-1alpha and NF-kappaB and microRNAs 135a and 199a\u20135p","volume":"184","author":"Gonsalves","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.11.030_b0140","first-page":"609","article-title":"Tumor necrosis factor alpha in children with sickle cell disease in stable condition","volume":"89","author":"Kuvibidila","year":"1997","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.cyto.2014.11.030_b0145","first-page":"619","article-title":"In vivo production of type 1 cytokines in healthy sickle cell disease patients","volume":"91","author":"Taylor","year":"1999","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.cyto.2014.11.030_b0150","first-page":"415","article-title":"Interferon production in sickle cell disease","volume":"9","author":"Taylor","year":"1990","journal-title":"Lymphokine Res"},{"key":"10.1016\/j.cyto.2014.11.030_b0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.moh.0000219656.50291.73","article-title":"Modifier genes and sickle cell anemia","volume":"13","author":"Steinberg","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.cyto.2014.11.030_b0160","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jpeds.2011.07.018","article-title":"Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia","volume":"160","author":"Darbari","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.cyto.2014.11.030_b0165","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.archoralbio.2012.11.006","article-title":"Serum cytokine profile among Brazilian children of African descent with periodontal inflammation and sickle cell anaemia","volume":"58","author":"Veiga","year":"2013","journal-title":"Arch Oral Biol"},{"issue":"27","key":"10.1016\/j.cyto.2014.11.030_b0170","doi-asserted-by":"crossref","first-page":"16357","DOI":"10.1074\/jbc.271.27.16357","article-title":"Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the anti-inflammatory effects of the cytokine","volume":"271","author":"Crawley","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2014.11.030_b0175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-5728(01)00444-1","article-title":"IL-10 promotes survival of microglia without activating Akt","volume":"122","author":"Strle","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cyto.2014.11.030_b0180","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1096\/fj.06-6084fje","article-title":"IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression","volume":"20","author":"Rajasingh","year":"2006","journal-title":"FASEB J"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614006139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614006139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:14:00Z","timestamp":1650932040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466614006139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1043466614006139"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2014.11.030","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum IL-6, IL-10, and TNF\u03b1 levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2014.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}